Leerink Upgrades Replimune Group (REPL) to Outperform

August 4, 2026 3:43 AM EDT Send to a Friend
Leerink analyst Daina Graybosch upgraded Replimune Group (NASDAQ: REPL) from Market Perform to Outperform with a price target of $17.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login